Vincenzo Ronca

ORCID: 0000-0003-0761-1333
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Diseases and Immunity
  • Liver Disease Diagnosis and Treatment
  • Pediatric Hepatobiliary Diseases and Treatments
  • Liver Disease and Transplantation
  • Gallbladder and Bile Duct Disorders
  • Organ Transplantation Techniques and Outcomes
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatitis Viruses Studies and Epidemiology
  • Drug Transport and Resistance Mechanisms
  • Organ Donation and Transplantation
  • Liver physiology and pathology
  • Hepatitis B Virus Studies
  • Renal Transplantation Outcomes and Treatments
  • T-cell and B-cell Immunology
  • Pancreatitis Pathology and Treatment
  • Hepatitis C virus research
  • Immunotherapy and Immune Responses
  • Macrophage Migration Inhibitory Factor
  • Robotics and Automated Systems
  • Renal Diseases and Glomerulopathies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Acute Lymphoblastic Leukemia research
  • Diabetes and associated disorders
  • Systemic Lupus Erythematosus Research
  • Venous Thromboembolism Diagnosis and Management

IRCCS Humanitas Research Hospital
2024-2025

University of Birmingham
2020-2025

ERN GUARD-Heart
2025

Humanitas University
2015-2025

NIHR Birmingham Biomedical Research Centre
2021-2025

Universität Hamburg
2025

University Medical Center Hamburg-Eppendorf
2025

Radboud University Nijmegen
2025

Radboud University Medical Center
2025

Medical University of Warsaw
2025

Marco Carbone Alessandra Nardi Steve Flack Guido Carpino Nikoletta Varvaropoulou and 95 more Caius Gavrila Ann Spicer Jonathan Badrock Francesca Bernuzzi Vincenzo Cardinale Holly F. Ainsworth Michael A. Heneghan Douglas Thorburn Andrew Bathgate Rebecca Jones James Neuberger Pier Maria Battezzati Massimo Zuin Simon D. Taylor‐Robinson Maria Francesca Donato John A. Kirby Robert Mitchell-Thain Annarosa Floreani Fotios Sampaziotis Luigi Muratori Domenico Alvaro Marco Marzioni Luca Miele Fabio Marra Edoardo G. Giannini Eugenio Gaudio Vincenzo Ronca Giulia Bonato Laura Cristoferi Federica Malinverno Alessio Gerussi Deborah Stocken Heather J. Cordell Gideon M. Hirschfield Graeme Alexander Richard Sandford David Jones Pietro Invernizzi George Mells Caradog Thomas Meshbah Rahman Tom Yapp Chin Lye Ch’ng Melanie Harrison Richard Sturgess Roman Galaska Chris Healey Jessica Whiteman Marek Czaijkowski Catherine Gray Anton Gunasekera Pranab Gyawli Purushothaman Premchand Steven Mann Keith Elliott Kapil Kapur Alan Watson Graham R. Foster Paul Trembling Javaid Subhani Rory Harvey Roger McCorry Carolyn Adgey Lucie Hobson Caroline Mulvaney-Jones Richard J. Evans Thiriloganathan Mathialahan David Ramanaden Jaber Gasem Greta Van Duyvenvoorde Christopher Shorrock Katie Seward Paul Southern Jeremy Tibble Ruth Penn Stephen Gorard Jane Maiden Rose Damant Altaf Palegwala Susan Jones Graeme Alexander George Mells Richard Sandford Jessica Whiteman Sunil Dolwani Martin Prince Valéria Damasceno Silvestre Matthew Foxton Eleanor Dungca Harriet Mitchison Natalie Wheatley Ian Gooding Helen Doyle Mazn Karmo Melanie Kent

10.1016/s2468-1253(18)30163-8 article EN ˜The œLancet. Gastroenterology & hepatology 2018-07-15

•Under real-world conditions, OCA was effective in ~43% of patients who were non-responders to UDCA, according Poise criteria.•Patients with cirrhosis showed lower efficacy (29.5%), mainly attributed reduced tolerability and higher discontinuation rate.•Patients overlap AIH-PBC a comparable pure PBC, ALT reduction at 6 months.•Most PBC are still need additional therapy if aiming normalise liver biochemistry. Background & aimsObeticholic acid (OCA) is the second-line treatment approved for...

10.1016/j.jhepr.2021.100248 article EN cc-by-nc-nd JHEP Reports 2021-01-27
Rosanna Asselta Elvezia Maria Paraboschi Alessio Gerussi Heather J. Cordell George Mells and 95 more Richard Sandford David Jones Minoru Nakamura Kazuko Ueno Yuki Hitomi Minae Kawashima Nao Nishida Katsushi Tokunaga Masao Nagasaki Atsushi Tanaka Ruqi Tang Zhiqiang Li Yongyong Shi Xiangdong Liu Ma Xiong Gideon M. Hirschfield Katherine A. Siminovitch Marco Carbone Giulia Cardamone Stefano Duga M. Eric Gershwin Michael F. Seldin Pietro Invernizzi Erin J. Walker Gang Xie Andy Mason Robert P. Myers Kevork Peltekian Cameron N. Ghent Elizabeth J. Atkinson Bruce Juran Kostas Lazaridis Yue Lu Xiangjun Gu Kaiyan Jing Chris Amos Andrea Affronti Maurizia Brunetto B. Coco Giancarlo Spinzi G. Elia Carlo Ferrari Ana Lleò Luigi Muratori Paolo Muratori Piero Portincasa Agostino Colli Savino Bruno Guido Colloredo Francesco Azzaroli Pietro Andreoné Maria Consiglia Bragazzi Domenico Alvaro Vincenzo Cardinale Nora Cazzagon Cristina Rigamonti Annarosa Floreani F. Rosina Antonio Ciaccio Laura Cristoferi Daphne D’Amato Federica Malinverno Clara Mancuso Sara Massironi Chiara Milani Sarah Elisabeth O’Donnell Vincenzo Ronca Donatella Barisani Pietro Lampertico Francesco Donato S. Fagiuoli Piero Luigi Almasio Edoardo G. Giannini C. Cursaro Massimo Colombo Luca Valenti Luca Miele Angelo Andriulli Grazia Anna Niro Ignazio Grattagliano Lorenzo Morini Giovanni Casella M. Vinci Pier Maria Battezzati Andrea Crosignani Massimo Zuin Alberto Mattalia Vincenza Calvaruso Sílvia Colombo A. Benedetti Marco Marzioni Andrea Galli Fabio Marra Mirko Tarocchi A. Picciotto

10.1053/j.gastro.2021.02.061 article EN Gastroenterology 2021-03-04

In autoimmune hepatitis, achieving complete biochemical remission (CBR) with current weight-based thiopurine dosing is challenging. We investigated whether patients could be stratified regarding CBR according to a target range of metabolites. Moreover, we explored the effects azathioprine dosage increases and co-therapy allopurinol low-dose thiopurines on metabolite profiles treatment response.

10.1097/hep.0000000000000940 article EN Hepatology 2024-05-29

Abstract The presence of CD8 + T cells in the cytoplasm biliary epithelial (BEC) has been correlated with damage associated primary cholangitis (PBC). Here, we characterise mechanism cell invasion into BEC. observed within BEC were large, eccentric, and expressed E-cadherin, CD103 CD69. They also not contained secondary vesicles. Internalisation required cytoskeletal rearrangements which facilitated contact Internalised both non-cirrhotic cirrhotic diseased liver tissues but enriched PBC...

10.1038/s41467-024-44910-2 article EN cc-by Nature Communications 2024-01-29

Background and Aims Liver fibrosis holds a relevant prognostic meaning in primary biliary cholangitis (PBC). Noninvasive evaluation using vibration‐controlled transient elastography (VCTE) is routinely performed. However, there limited evidence on its accuracy at diagnosis PBC. We aimed to estimate the diagnostic of VCTE assessing advanced (AF) disease presentation Approach Results collected data from 167 consecutive treatment‐naïve PBC patients who underwent liver biopsy (LB) six Italian...

10.1002/hep.31810 article EN cc-by-nc Hepatology 2021-03-16

Primary Biliary Cholangitis (PBC) is a chronic cholestatic liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to fibrosis, and potentially cirrhosis. PBC has been considered prototypical autoimmune condition, given presence specific autoantibodies immune response against well-defined mitochondrial autoantigens. Further evidence supports interaction immunogenetic environmental factors in aetiology PBC. An immunological attack on biliary epithelial...

10.1097/hep.0000000000001225 article EN Hepatology 2025-01-03

The presented work aimed to investigate neurophysiological markers of sense presence in virtual reality. study was based on developing and preliminary validating a -based approach for evaluation. A VR environment designed modulate multisensory conditions, including visual, auditory, vibrotactile stimuli. EEG, ECG, EDA signals were recorded. Mutual Information-based index (SoPMI) developed as synthetic metric presence, integrating multiple physiological signals. Signal preprocessing analysis...

10.1109/tbme.2025.3541438 article EN cc-by-nc-nd IEEE Transactions on Biomedical Engineering 2025-01-01

Background: Impaired health-related quality of life (HRQoL) contributes to the overall disease burden in autoimmune hepatitis (AIH). This study aimed evaluate HRQoL people with AIH and identify potentially modifiable factors associated impaired using validated patient-reported outcome measures. Methods: Adult patients diagnosed at 12 European centers were enrolled this prospective, cross-sectional from July 2020-June 2023. was assessed Physical Component Score (PCS) Mental (MCS) 12-item...

10.1097/hep.0000000000001271 article EN Hepatology 2025-02-19

Obeticholic acid (OCA) has recently been restricted in patients with primary biliary cholangitis (PBC) "advanced cirrhosis" because of its narrow therapeutic index. We aimed to better define the predicting factors hepatic serious adverse events (SAEs) and non-response cirrhotic undergoing OCA therapy.Safety efficacy treatment were evaluated a cohort consecutive PBC started OCA. response was according Poise criteria. Risk for SAEs reported as risk ratios (RR) 95% confidence intervals...

10.1111/liv.15386 article EN cc-by Liver International 2022-08-06
Coming Soon ...